Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application.
about
Bias in published cost effectiveness studies: systematic review.Consensus Decision Models for Biologics in Rheumatoid and Psoriatic Arthritis: Recommendations of a Multidisciplinary Working Party.Validation of population-based disease simulation models: a review of concepts and methodsA review of economic evaluation models for cardiac resynchronization therapy with implantable cardioverter defibrillators in patients with heart failureHow to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: data extraction, risk of bias, and transferability (part 3/3).Risk of bias in model-based economic evaluations: the ECOBIAS checklist.Specific guidelines for assessing and improving the methodological quality of economic evaluations of newborn screeningEconomic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases.A critical review of model-based economic studies of depression: modelling techniques, model structure and data sources.Economic evaluations in bipolar disorder: a systematic review and critical appraisal.The cost-effectiveness of tracking newborns with bilateral hearing impairment in Bavaria: a decision-analytic modelRapid magnetic resonance imaging for diagnosing cancer-related low back pain.Systematic narrative review of decision frameworks to select the appropriate modelling approaches for health economic evaluationsEstimating the cost-effectiveness of lifestyle intervention programmes to prevent diabetes based on an example from Germany: Markov modelling.Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment.Chapter 10: deciding whether to complement a systematic review of medical tests with decision modeling.Protocol of the impact of alternative social assistance disbursement on drug-related harm (TASA) study: a randomized controlled trial to evaluate changes to payment timing and frequency among people who use illicit drugs.Economic outcomes associated with atypical antipsychotics in bipolar disorder: a systematic review.Assessing generalisability in model-based economic evaluation studies: a structured review in osteoporosis.Wickedness or folly? The ethics of NICE's decisions.Review of Australian health economic evaluation - 245 interventions: what can we say about cost effectiveness?Economic evaluation and catheter-related bloodstream infectionsChoosing an epidemiological model structure for the economic evaluation of non-communicable disease public health interventions.Requirements for benefit assessment in Germany and England - overview and comparison.Modelling the cost effectiveness of disease-modifying treatments for multiple sclerosis: issues to consider.Evidence synthesis for decision making 5: the baseline natural history modelCost-effectiveness of cardiac resynchronization therapy in the MADIT-CRT trial.Accounting for treatment by center interaction in sample size determinations and the use of surrogate outcomes in the pessary for the prevention of preterm birth trial: a simulation studyCost-effectiveness analysis comparing two approaches for empirical antifungal therapy in hematological patients with persistent febrile neutropenia.General population versus disease-specific event rate and cost estimates: potential bias for economic appraisals.Sensitivity analysis in cost-effectiveness studies: from guidelines to practice.The use of decision-analytic models in Parkinson's disease: a systematic review and critical appraisal.Evidence for the credibility of health economic models for health policy decision-making: a systematic literature review of screening for abdominal aortic aneurysms.Economic evaluations of adult weight management interventions: a systematic literature review focusing on methods used for determining health impacts.Pioglitazone and vitamin E for nonalcoholic steatohepatitis: a cost utility analysis.Model performance evaluation (validation and calibration) in model-based studies of therapeutic interventions for cardiovascular diseases : a review and suggested reporting framework.Model-based cost-effectiveness analyses for prostate cancer chemoprevention : a review and summary of challenges.Systematic review and quality assessment of cost-effectiveness analysis of pharmaceutical therapies for advanced colorectal cancer.International standards for health economic evaluation with a focus on the German approach.A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures.
P2860
Q24541365-1CA328B0-C010-40CA-A29A-9D362C964B7CQ27335069-C2EA531A-461F-4CC6-B04C-EDF33C2B269FQ28744274-09058457-AFB2-4286-B625-26B2D406C8A6Q30244099-D08E6EE7-3587-4CAB-B56E-AC64465F1FD4Q30244313-4E32BF1C-0F76-4718-A7A7-71F1ADBBE012Q30252032-2B3555D5-98AE-4F2D-8457-7AE2946429F8Q31088945-4F74FA4E-C096-4B5F-ADC5-62AA1E8F3B5BQ34196906-1045AEA6-1632-4AC4-8893-C5C38A888544Q34214236-3CC9923E-5504-4736-AE76-0DE6C859CBDFQ34424079-BC2AB591-19A1-4AC3-8C8D-ADF1768B39D5Q34484234-C8FD7216-F8EA-4F64-98C1-1C7D1ABA959FQ34741317-49A62454-8F15-4F8E-B49F-A81DD9CA9E7EQ35665481-E234C249-321B-4F9F-A3F1-E8BB3EE10A61Q35666642-7A18FA4E-95CA-4038-9712-CB8DCBB92430Q35856799-2F966311-33CA-4512-9215-962201F28CD8Q35999029-BEF69AA6-BF27-4171-970A-1EA8E95F788FQ36090208-AAB00D04-D9C8-47FF-AA6D-42E7FE59211AQ36274272-F4F3DECB-44D8-444C-946E-8B27FA43D302Q36439111-A5138656-E9F7-4B4A-90C2-0639CF4BE47BQ36525500-AFBE723D-E97D-4C3A-9402-E9E67EF9F82CQ36700357-F758675F-A84E-4028-B221-F909365C5FDEQ36842051-61A9F2D9-5787-4F3D-94CA-3A1F6536A5D7Q36871294-6AE934BA-3215-4EA8-AC92-B8E034449014Q36944500-B79351C3-62D1-4A91-B9A4-4D3D530A377DQ36968664-B426BB33-5395-4C0E-9949-FD017961D06EQ36991723-DA3AD893-9AB8-4C04-9D63-6A272E9585EBQ37011916-5A90AB8D-D246-47E5-802F-1B48819420B4Q37064401-B32B643B-0729-4BB3-BD81-289E7737AF72Q37263911-8C3333A8-41F4-4157-B6FA-23B3C1E6B716Q37780536-4C2797EB-442E-41DF-8EAE-DADF575EDE23Q37851945-33F683CA-0AAA-41B5-BBA5-65E1E7AD5B74Q37891050-B0FBC199-09AF-4E7D-AE91-FD85D71550DBQ37939813-1ADA8384-DB29-4D74-ADB0-2C8B482BC503Q37996073-D2F273A4-50EE-4421-8EED-0762176B909DQ38019467-003F27C0-51C8-46FC-8418-3B99DA61C894Q38086133-7925DBE0-7ED8-4EA8-A5AF-577E340AC8CAQ38092015-2331AECC-C990-4964-9B56-65D3317A1553Q38095230-C3378306-7D5B-493D-9176-1FD9741C5BAFQ38101996-050B5CCB-318F-4D0F-AA09-64BD9330173AQ38155095-70FBA994-FFA6-4704-8233-631D39DA6C9D
P2860
Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Assessing quality in decision ...... rk and example of application.
@ast
Assessing quality in decision ...... rk and example of application.
@en
Assessing quality in decision ...... rk and example of application.
@nl
type
label
Assessing quality in decision ...... rk and example of application.
@ast
Assessing quality in decision ...... rk and example of application.
@en
Assessing quality in decision ...... rk and example of application.
@nl
prefLabel
Assessing quality in decision ...... rk and example of application.
@ast
Assessing quality in decision ...... rk and example of application.
@en
Assessing quality in decision ...... rk and example of application.
@nl
P2093
P1433
P1476
Assessing quality in decision ...... rk and example of application.
@en
P2093
P2860
P304
P356
10.2165/00019053-200017050-00005
P577
2000-05-01T00:00:00Z
P6179
1009215928